What is DA Davidson’s Forecast for PBH FY2025 Earnings?

Prestige Consumer Healthcare Inc. (NYSE:PBH) – Investment analysts at DA Davidson upped their FY2025 earnings estimates for shares of Prestige Consumer Healthcare in a research note issued on Monday, February 10th. DA Davidson analyst L. Weiser now anticipates that the company will post earnings of $4.50 per share for the year, up from their prior estimate of $4.46. DA Davidson currently has a “Buy” rating and a $104.00 target price on the stock. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.50 per share. DA Davidson also issued estimates for Prestige Consumer Healthcare’s Q4 2025 earnings at $1.30 EPS.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%.

Several other equities analysts also recently commented on the stock. Sidoti downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research note on Monday, December 9th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Canaccord Genuity Group lifted their price objective on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday. Finally, Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Prestige Consumer Healthcare currently has an average rating of “Moderate Buy” and an average price target of $92.50.

Prestige Consumer Healthcare Stock Up 0.3 %

Shares of PBH opened at $87.29 on Tuesday. The firm has a market cap of $4.31 billion, a P/E ratio of 20.44, a P/E/G ratio of 2.43 and a beta of 0.50. The stock has a 50 day simple moving average of $79.23 and a two-hundred day simple moving average of $75.51. Prestige Consumer Healthcare has a 1 year low of $62.35 and a 1 year high of $88.36. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.10.

Insider Buying and Selling at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 10,875 shares of the firm’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total transaction of $898,275.00. Following the completion of the sale, the chief executive officer now directly owns 320,952 shares in the company, valued at approximately $26,510,635.20. This trade represents a 3.28 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Prestige Consumer Healthcare

A number of institutional investors have recently made changes to their positions in the company. Kestra Investment Management LLC purchased a new position in shares of Prestige Consumer Healthcare in the fourth quarter worth $27,000. Northwestern Mutual Wealth Management Co. lifted its stake in Prestige Consumer Healthcare by 562.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after acquiring an additional 433 shares during the period. nVerses Capital LLC boosted its holdings in shares of Prestige Consumer Healthcare by 200.0% during the 3rd quarter. nVerses Capital LLC now owns 600 shares of the company’s stock valued at $43,000 after acquiring an additional 400 shares during the last quarter. Huntington National Bank grew its stake in shares of Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after acquiring an additional 181 shares during the period. Finally, International Assets Investment Management LLC lifted its position in Prestige Consumer Healthcare by 7,112.5% during the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock valued at $83,000 after purchasing an additional 1,138 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.